Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 14.60
-0.22 (-1.48%)
Mar 9, 2026, 4:51 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 1.97 billion as of March 9, 2026. Its market cap has increased by 23.64% in one year.
Market Cap
1.97B
Enterprise Value
1.74B
Revenue
349.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.60
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 1.97B, an increase of 1,385.87%. That is a compound annual growth rate of 23.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 2.04B |
| Saniona AB | 2.01B |
| Vicore Pharma Holding AB | 2.75B |
| BioInvent International AB | 1.49B |
| Flerie AB | 2.87B |
| Hansa Biopharma AB | 3.02B |
| Genovis AB (publ.) | 1.10B |
| Cantargia AB | 1.02B |